author-photo

Robert Kassees

Genentech

11

Papers

519

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

368 GDC-0068, a Novel and Selective Akt Inhibitor Demonstrates Improvement in Anti-tumor Activity When Combined with Androgen Receptor Pathway Antagonists, MDV3100 and Abiraterone, in Prostate Cancer Models

2012 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Preclinical Disposition of GDC-0973 and Prospective and Retrospective Analysis of Human Dose and Efficacy Predictions

2012 Drug Metabolism and Disposition
Show All
- Source
- Cite
- Save
Citations (27)
Abstract 873: Combined targeting of Akt and MEK with the Akt inhibitor GDC-0068 and MEK inhibitor GDC-0973 demonstrates synergistic anti-tumor effects

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Navitoclax Enhances the Efficacy of Taxanes in Non–Small Cell Lung Cancer Models

2011 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (74)
GDC-0980IsaNovelClassIPI3K/mTORKinaseInhibitorwith RobustActivityinCancerModelsDrivenbythePI3KPathway

2011
Show All
- Source
- Cite
- Save
Citations (0)
Navitoclax enhances the activity of taxanes in non-small cell lung carcinoma (NSCLC) models

2010 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
220 POSTER Combination of class I PI3K inhibitor, GDC-0941, with standard of care therapeutics results in enhanced anti-tumor responses in human cancer models in vitro and in vivo

2008 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (1)